Endocard Pacing Lead Long Length PL200
by Diag Corp. 510(k)
Active
510(k) K800349
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK800349 | Date28 May 1980 | StatusActive |
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Recalls
No FDA recalls on record, checked 22 Oct 2026.
Specification
- 510(k) Number
- FDA Product Code
- DTB
- Device Class
- Class III
- Regulation
- 21 CFR Part 870.3680
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 18 Sep 2026
The Endocard Pacing Lead Long Length PL200 is a permanent pacemaker electrode, classified under product code DTB. This device is designed to deliver electrical stimulation to the heart’s endocardium, helping regulate heart rhythm in patients with bradycardia or conduction disorders.
Supplied as a single-use device, the PL200 is intended for implantation in cardiac pacing procedures. It has received FDA 510(k) clearance under the traditional review pathway, with a decision date of September 14, 1977. The device adheres to Class III regulatory requirements for permanent pacemaker electrodes, ensuring compliance with medical specialty standards for cardiovascular applications.
Other devices from Diag Corp.
Questions
AI-generated answers, 18 Sep 2026
What is the primary use of the Endocard Pacing Lead Long Length PL200 in clinical practice?
The Endocard Pacing Lead PL200 is designed to deliver electrical stimulation directly to the heart’s endocardium, helping regulate abnormal heart rhythms (bradycardia) or conduction disorders in patients requiring permanent pacing. It is intended for implantation during cardiac pacing procedures to ensure proper heart function.
Is the Endocard Pacing Lead PL200 meant for single-use or can it be reused?
The PL200 is explicitly supplied as a single-use device, meaning it is intended for one-time implantation and should not be reused. Reuse could compromise sterility and patient safety, so adherence to single-use guidelines is critical.
How was the FDA clearance for this device determined, and what does that mean for clinicians?
The PL200 received FDA 510(k) clearance under the traditional review pathway, with a decision date of September 14, 1977. This classification means it was deemed *substantially equivalent* to a legally marketed predicate device, ensuring it meets regulatory standards for permanent pacemaker electrodes (Class III). Clinicians can rely on its compliance with cardiovascular medical specialty standards.
What storage or handling considerations should be followed for the PL200?
While the provided data does not specify exact storage conditions, as a single-use, implanted medical device, the PL200 should be stored in a clean, dry environment protected from contamination or physical damage. Follow manufacturer guidelines (Diag Corp.) for packaging integrity and expiration dates to ensure sterility and functionality before use.